Dr. Fero is a medical oncologist with clinical expertise in bone marrow transplantation. He treats patients with leukemia, lymphoma, and myelodysplastic syndrome.
Helping to give patients the confidence that they can overcome adversity.
Medical genetics, oncology, hematopoietic stem cell transplantation in treatment of malignancy and diseases of the bone marrow.
- Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Associate Professor, Medical Oncology Division, University of Washington School of Medicine
- University of California, Irvine, 1990
- University of California, Berkeley, 1984
- Residencies: University of Washington, Medical School, 1996 Mayo Graduate School of Medicine, 1993
- Board Certification: American Board of Internal Medicine,
- Medical Oncology, 1996
- American Board of Internal Medicine, Internal Medicine, 1993
For more information about Dr. Matthew L. Fero's clinical and research expertise, click here.
Matthew Fero, MD decided to go into medicine because it would allow him to combine his love of science and his desire to have a positive impact on the peoples’ health.
“My first aim is always to help patients gain a better understanding of their condition, even as I gain a better understanding of their experiences and preferences,” he says. “My second aim is to provide encouragement as they confront difficult decisions or clinical conditions. Ultimately, my hope is to help improve the quality of life of my patients, even with seemingly small things. Every patient is a unique individual, so the ideal approaches and solutions may be as varied as they are.”
Dr. Fero has a research lab in the Thomas building at Fred Hutchinson Cancer Research Center where he studies the genes that go awry during the development of lymphoma and leukemia. This includes genes that normally control the cell division cycle as well a micro RNA, small regulatory molecules that have broad effects on cellular function.
The initial aim of Dr. Fero’s research is to understand the normal biological functions of these genes and what happens when they go awry in cancers. The ultimate goal is to develop new targets for cancer treatments coupled with clinical markers that predict who would best be served by new therapies.
“For cancer treatment in the next decade, I would like to see the general attitude about cancer change with a greater understanding that not all cancers are the same,” Dr. Fero says. “This would be coupled with improved treatments and diagnostics such that many cancers will prove to be highly curable, while others can be managed as a chronic condition, much like heart disease or diabetes today.”
Outside of work, Dr. Fero says his favorite time of the day is getting on his bike to go to or from work. “That definitely helps me unwind,” he says. “My wife, Jutta, is also a researcher here at Hutch, so I am lucky to have lunches with her on occasion. I am a big fan of the UW's Track and Cross Country team, as we have two daughters who have competed for their teams. When we're not watching athletes run in circles, I like to hike or ski in the local mountains, and to swim in Lake Washington.”